HealthCap
HealthCap, established in 1996, is a Stockholm-based venture capital firm specializing in the life sciences sector. With over €800 million in committed capital, it is one of Europe's largest dedicated life sciences investors. The firm invests globally across various stages, from early to late-stage ventures, focusing on pharmaceuticals, biotechnology, and other life sciences sectors. HealthCap operates through multiple funds, with its most recent fund, HealthCap VIII, targeting pharmaceuticals and biotechnology. The firm's exclusive investment advisor is the Odlander Fredrikson Group.
Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate, modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threatening complications. Hemab Therapeutics was established in 2017 in Copenhagen, Hovedstaden by Johan H. Faber and Mads Behrndt.
Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate, modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threatening complications. Hemab Therapeutics was established in 2017 in Copenhagen, Hovedstaden by Johan H. Faber and Mads Behrndt.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.